We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Software Monitoring Helps Detect ICD Malfunctions

By HospiMedica International staff writers
Posted on 22 Mar 2012
A software-monitoring program that tracks implantable cardioverter-defibrillator (ICD) function could detect problems with the devices earlier than current monitoring processes, according to a new study.

Researchers at the Minneapolis Heart Institute Foundation (MN, USA) performed simulated prospective monthly full-cohort and propensity-matched comparative survival analyses on 3-center databases of the Sprint Fidelis--which was eventually recalled--and the Quattro Secure ICD, using a commercially available automated surveillance tool that was preset to detect early signals that an ICD was underperforming and trigger an alert if the log rank probability value was lower than 0.05. More...
Patients in both databases had their ICDs implanted between 2001 and 2008.

The results showed that the surveillance software simulated and detected problems with the recalled leads at least a year before recall; in all, 84 of 1,035 Fidelis (8.1%) and 23 of 1,675 Quattro (1.4%) leads failed, with the simulated full-cohort analysis triggering a sustained alert for Fidelis leads beginning 13 months after the first implant, and two years before Fidelis leads were actually removed from the market. In the propensity-matched analysis, the alert triggered 22 months after the first Fidelis implant and more than one year before the lead was recalled. The study was published ahead of print on March 6, 2012, in Circulation.

"The software works; looking at ICD patients implanted years ago, we showed that the automated program detects medical device problems faster than current approaches,” said lead author consulting cardiologist Robert Hauser, MD. “Pinpointing the malfunction a year earlier in this case could have spared thousands of patients the health risks, costs and inconvenience of receiving a device prone to failure.”

ICDs monitor heart rhythms and deliver electric shocks to restore normal rhythm when life-threatening, irregular heartbeats occur. However, the surgically implanted devices can malfunction, particularly in the leads that connect them to the heart, causing injury or death. ICD manufacturers track repeated malfunctions and issue recalls if they are widespread, but by the time of the recall, thousands of the devices have usually already been implanted in patients.

Related Links:

Minneapolis Heart Institute Foundation



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Electrode Solution and Skin Prep
Signaspray
PACS Workstation
PaxeraView PRO
Exam Table
PF400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.